SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A4C2C577678A250B17A1EA074C3C94C1CE212307ED214EC7AFF60E19B6A4DE978151A2FFAD8DBD1A0FC269F077C80AE5>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A4C2C577678A250B17A1EA074C3C94C1CE212307ED214EC7AFF60E19B6A4DE978151A2FFAD8DBD1A0FC269F077C80AE5
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A4C2C577678A250B17A1EA074C3C94C1CE212307ED214EC7AFF60E19B6A4DE978151A2FFAD8DBD1A0FC269F077C80AE5
http://www.w3.org/2000/01/rdf-schema#comment
"Fas DR4 and DR5 are activated in drug-sensitive cells in response to anticancer drugs depending on the cytotoxic effect of each drug"
xsd:string
http://purl.uniprot.org/uniprot/#_39855AE0FB4569FCC61CBDEC796EE3BE1A6BF92A0516198FC18BFF1D8A25E312EB7028A340C60D2E916407F66516B8D9
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A4C2C577678A250B17A1EA074C3C94C1CE212307ED214EC7AFF60E19B6A4DE978151A2FFAD8DBD1A0FC269F077C80AE5
http://purl.uniprot.org/uniprot/Q6FH58
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A4C2C577678A250B17A1EA074C3C94C1CE212307ED214EC7AFF60E19B6A4DE978151A2FFAD8DBD1A0FC269F077C80AE5
http://purl.uniprot.org/uniprot/#_Q6FH58-mappedCitation-14534720
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A4C2C577678A250B17A1EA074C3C94C1CE212307ED214EC7AFF60E19B6A4DE978151A2FFAD8DBD1A0FC269F077C80AE5